KLK3 and prostate carcinoma: Nonetheless, this PET tracer was sufficient in detecting AR-dependent changes in PSA expression levels in mouse tumour lesions, as well as in distinguishing PCa cells within bone lesions - both of which may be useful in the staging and clinical evaluation of advanced prostate cancer [18].